Response to "Disparities in the use of chemotherapy and monoclonal antibody therapy for elderly advanced colorectal cancer patients in the community oncology setting"

Oncologist. 2009 Jan;14(1):104-5; author reply 106-7. doi: 10.1634/theoncologist.2008-0222.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Age Factors
  • Aged
  • Antibodies, Monoclonal / administration & dosage*
  • Antineoplastic Agents / administration & dosage*
  • Antineoplastic Combined Chemotherapy Protocols / administration & dosage*
  • Colorectal Neoplasms / drug therapy*
  • Humans
  • Survival Rate

Substances

  • Antibodies, Monoclonal
  • Antineoplastic Agents